Anti-müllerian hormone in the pathophysiology and diagnosis of polycystic ovarian syndrome. Issue 6 (December 2018)

• Record Type: Journal Article
• Authors: Dumont, Agathe; Robin, Geoffroy; Dewailly, Didier
• Is Part Of: Current opinion in endocrinology, diabetes and obesity. Volume 25:Issue 6(2018:Dec.)
• Publication Date: 2018-12
• Subjects: anti-Müllerian hormone -- assisted reproductive technologies -- menopause prediction -- ovarian reserve -- polycystic ovary syndrome; Endocrinology -- Periodicals; Diabetes -- Periodicals; Obesity -- Periodicals; Diabetes Mellitus -- Periodicals; Endocrine System Diseases -- Periodicals; Endocrine Glands -- Periodicals; Obesity -- Periodicals; Endocrinologie -- Périodiques; Diabète -- Périodiques; Obésité -- Périodiques; Diabetes; Endocrinology; Obesity; Periodicals; 616.4
• DOI: 10.1097/MED.0000000000000445
• Languages: English
• ISSNs: 1752-296X

Abstract

Abstract : Purpose of review: Polycystic ovarian syndrome (PCOS) is the most common cause of chronic anovulation and hyperandrogenism in young women and represents a true public health concern and an economic burden. Recent findings: The pathophysiology of PCOS is still not fully understood, but progresses have been made and the relationships between anti mullerian hormone (AMH), follicle stimulating hormone, luteinizing hormone, E2 and androgens have been explored. The follicle excess plays a central role in the syndrome and AMH is definitively a major component of this phenomena. Summary: The aim of this chapter is to present the recent work studying the role of AMH in the pathophysiology of PCOS and to discuss the improvement that serum AMH assay brings in the diagnosis of PCOS.